Our speakers

Diwakar Dayal, Managing Director, SentinelOne

Dominic Goh, Principal, Harbourvest Partners

Dominic Goh joined HarbourVest in 2012 and focuses on secondary investments. This includes analyzing, structuring, and monitoring a wide range of secondary transaction types.

Dominic was previously at Coller Capital where he evaluated secondary opportunities, and contributed to deal sourcing and fundraising efforts in Asia. Prior to that, he was an investment banking associate at ABN AMRO London in the Financial Institutions Group.

Dominic received a BSc (first class honours) in Accounting & Finance from the London School of Economics and Political Science in 2005. Dominic is fluent in Mandarin.

Donald Chan, Managing Director, Asia Pacific, CDP

Dr A.Velumani, Founder, Thyrocare Technologies Ltd

Dr A Velumani, an Ex BARC research scientist is the promotor of Thyrocare Technologies Limited. It was started in 1996, after completing his PhD in Thyroid Pathophysiology and Immunodiagnostics. Today Thyrocare is the industry leader, trend setter and innovators in Indian Diagnostic industry. A company with a network of more than 10,000 Service Centers across the country, its laboratory is certified ISO 9001-2000, accredited by NABL and to keep it ready to take on the global market, in 2007, it has been accredited by the College of American Pathologists (CAP), a global accrediting organisation.

Thyrocare network is vast enough to process in a day 50,000 investigations as on date and it has a capacity to process 5,00,000 investigations per day in its current facilities in Mumbai. This unique, single laboratory model could take on the entire country market, using its innovative and intelligent logistics.  Using an air cargo driven logistics for incoming specimens, the laboratory receives every night, same night, before midnight, from 90% of Indian geography. With a backend prowess in IT, this webserver controlled operations deliver reports every morning in every part of the country.

With an impressive volume driven profitablity and focussed, dynamic and scalable model, now it looks at global market and it beleives that it can operate as a global hub for the clinical chemistry segment. Invitro success can be also tried in in-vivo business if ideal partners are identified. It has a compounded annualgrowth of 25% and is doing currently 50 crores of turnover.

Dr Amit Kakar, Managing Partner and Head of Asia, Novo Holdings Equity Asia Pte Ltd

Dr Amit Varma, MD, Healthcare Religare Enterprises Limited

Dr Amit Varma currently operates as President Health Care, Religare Enterprises and Director, Critical Care Medicine, Fortis Escorts group of Hospitals, India. Having completed his MBBS and MD from University of Delhi, Dr Varma further completed his residency from the State University of New York. Thereafter he went on to pursue fellowships in critical care at the University of Pittsburgh Medical Center, and sub specialized in cardiac critical care at the Cleveland Clinic. Alongside this, he also attended courses for an Executive MBA at the University of Chicago.

After almost a decade in USA, Dr Varma began his professional journey in India at the Manipal Heart Foundation in Bangalore. He subsequently moved on to the Narayan Hrudayalaya Hospital as the consultant- in-charge of Critical Care. Early in 2003, Dr Varma joined Fortis Healthcare, where he has and continues to perform multiple administrative and clinical roles. He currently runs the integrated critical care services for Fortis Healthcare ICU network, which today comprises of a strong three-Hundred beds and helps in ormulation of Medical Strategy.

At Religare from 2009, Dr Varma is actively engaged in all healthcare initiatives of the company, playing an advisory and steering role, overlooking and further initiating all healthcare related businesses, providing medical expertise, insight and credibility in all healthcare related verticals such as Health Insurance venture, Healthcare IT, Super Religare Labs and Religare Wellness. He also sits on the Board and Investment committee of the 125$ million Milestone Religare Private Equity fund which is investing domestically in the healthcare and education fields.

Dr Asad Moopen, Chairman, DM Healthcare Pvt. Ltd.

Dr Moopen commenced his journey in healthcare 22 years back in the Middle East. He started his first clinic in Dubai in 1987 with only two doctors and now owns a chain of 70 clinics and pharmacies across GCC countries, the 60-bed Medcare Hospital, Dubai and the 20-bed Al Rafa Hospital for Maternity and Surgery, Dubai.

His strong determination and vision to become the number one in the Asian subcontinent and the Middle East, led him and his team to this great journey towards quality healthcare for all.

Realizing India and the Middle East had recently emerged as favourite destinations for healthcare investment. Dr Azad realized the potential, responded to these emerging markets, & rolled out a five-year roadmap for investing Rs.1,500 Crore in India and the Gulf Cooperative Council (GCC) countries. The MedCity in Kerala, an array of Greenfield projects, acquisitions across India and constructing 10 hospitals and 50 clinics and pharmacies in the GCC countries.Dr Azad Moopen, a true visionary, believes and states that in the race of excellence there is no finishing line.

Dr Ashwin Naik, Co-Founder and CEO, Vaatsalya Healthcare

Ashwin, founder of Vaatsalya, has more than 10 years experience in the life sciences and healthcare industry. Prior to founding Vaatsalya, Ashwin was Vice President of Business Development and Informatics, Triesta Sciences, a specialty clinical research organization involved in conducting advanced genomics based research in the field of oncology. Prior to that, he has worked in various capacities at Molecular Connections (Bangalore/Rockville), Celera Genomics (Maryland), Los Alamos National Laboratory (New Mexico) and Genetic Information Research Institute (California).

Ashwin has a medical degree from Karnatak Medical College, Hubli and a masters degree from University of Houston, Texas.

Dr G.S.K.Velu, MD, Trivitron Medical Services Pvt. Ltd

Dr. G.S.K Velu who has over 18 years of experience in the diagnostics and healthcare industry, and has worked in several multinational companies such as Ciba Corn Diagnostics, Chevron Diagnostics etc., in the capacity of Director (South Asia). He completed his graduation in Pharmaceutical Engineering from BITS Pilani and Post Graduated in Business Administration from Loyala Institute of Administration (LIBA) Chennai and Ph.D in Pharmacology from Indian Board of Alternative Medicines, Calcutta. He is also in the honorary faculty of Sri Ramachandra Hospital and Research Institute (Deemed) University.

He is also in the Board of Several Diagnostics and Medical Devices Companies in India and elsewhere.  He is the Founder and Managing Director of one of the most successful medical device and diagnostics company, Trivitron.  He contributes with his expertise in corporate marketing and diagnostic sales. He has been awarded the Entrepreneur of the year 2006 by Modern Medicare Magazine  which is a leading healthcare magazine.

Dr Harish Pillai, CEO, Aster Medcity

A healthcare professional with    exceptional leadership skills, Dr. Harish Pillai joined    the Aster DM Healthcare Group as the CEO of Aster Medcity in the year 2013. Set in 40 waterfront acres, Aster Medcity Kochi is a USD 300 million green field medical township project. The Phase I of the project, which comprises one Multispeciality Hospital, eight    separate Centres of Excellence, is complete. Aster Medcity is the first quaternary care hospital in Kerala to win the JCI Accreditation. The hospital is first in India to receive a host of accreditations and awards within    one year of opening and includes the NABH Accreditation, Green OT (Operation Theatre) Certification by Bureau Veritas, ISO 22000 Certification and the first-ever NABH Award for Excellence in Nursing.

In just 2 years, Dr. Harish Pillai was promoted as the CEO of all Aster DM Hospitalsin Kerala, which includes the 670-bed Aster Medcity    Kochi; MIMS Calicut, India’s first NABH accredited 600-bed tertiary care hospital; MIMS Kottakkal, a 150-bed secondary care hospital and DM WIMS, Wayanad, a 300-bed hospital and medical college.

Prior to joining Aster DM Healthcare, Dr. Harish Pillai was the CEO of Egypt’s biggest private tertiary care hospital - As Salam International Hospital, Cairo, for over 7 years. During his tenure    as the CEO, he was the functional head of the 1300 plus staff team and helped the organisation attain consistent annual growth of over 16% even during the Egyptian Revolution in the year 2011. Under his leadership, the Hospital won the JCI accreditation and charted a growth turnover from 16.65 million USD in 2006 to 43.7 million USD in 2012 with an EBITDA of 18%.

Dr. Harish Pillai, who did his medical schooling at the Kasturba Medical College, Mangalore, started his career in hospital management with the Apollo Hospital group after completing his first Masters in Hospital Administration from the Apollo Institute of Hospital Administration, Hyderabad, where he won the Dr Prathap C Reddy Award for Overall Excellence. He then went on to complete his Masters in Business Administration - International Hospital and Healthcare Management from the Frankfurt School of Finance & Management, Germany, where he was awarded the Best Student for his distinguished academic record. He then joined the Belhoul Speciality Hospital, Dubai, UAE, as General Manager - Operations, and was soon promoted as the Hospital Director.

One of the most influential leaders in the Indian healthcare industry, Dr. Harish Pillai has been nominated to the board of Members of the Joint Commission International (JCI) Standards International Advisory Panel. He is the current Convener of the Healthcare Panel of Confederation of Indian Industries - CII Kerala State Council; the past Chairman of Board of Directors of New Cairo British International School, Egypt and the past President of the Indian Community Association of Egypt.

Dr. Harish Pillai, who was featured among the top 25 healthcare influencers in India by the Healthcare Executive Magazine (January 2015 edition), won the Best CEO of the Year Award (2015) at the CMO National Awards for Healthcare Excellence.